Sorrento Therapeutics, Inc. Profile Avatar - Palmy Investing

Sorrento Therapeutics, Inc.

Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. Th…

Biotechnology
US, San Diego [HQ]

Risk Factors

By Management
Not Available

    No Risk Factor available yet. You can request "Risk Factors" through an email.

End of SRNE's Analysis
CIK: 850261 CUSIP: 83587F202 ISIN: US83587F2020 LEI: - UEI: -
Secondary Listings
SRNE has no secondary listings inside our databases.